American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Dollar Tree
DLTR
|
$193M |
| 2 |
Procter & Gamble
PG
|
$168M |
| 3 |
Microchip Technology
MCHP
|
$165M |
| 4 |
PepsiCo
PEP
|
$164M |
| 5 |
Genuine Parts
GPC
|
$151M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$356M |
| 2 |
AT&T
T
|
$177M |
| 3 |
PNC Financial Services
PNC
|
$160M |
| 4 |
Wynn Resorts
WYNN
|
$157M |
| 5 |
Autodesk
ADSK
|
$154M |
Sector Composition
| 1 | Financials | 16.41% |
| 2 | Healthcare | 13.41% |
| 3 | Technology | 13.37% |
| 4 | Consumer Discretionary | 11.12% |
| 5 | Industrials | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regeneron Pharmaceuticals
REGN
$61.5B
| $330M | 0.33% | 957,189 +79,602 | +9% | +$27.4M |
|
77
Costco
COST
$418B
| $330M | 0.33% | 1,749,272 -67,816 | -4% | -$12.8M |
|
|
PXD
78
DELISTED
Pioneer Natural Resource Co.
PXD
| $329M | 0.33% | 1,914,410 -339,613 | -15% | -$58.3M |
|
79
Roper Technologies
ROP
$56.6B
| $326M | 0.33% | 1,160,274 +20,319 | +2% | +$5.7M |
|
80
Bank of New York Mellon
BK
$74.5B
| $322M | 0.33% | 6,250,925 -307,028 | -5% | -$15.8M |
|
81
Texas Instruments
TXN
$184B
| $321M | 0.33% | 3,090,524 +28,086 | +0.9% | +$2.92M |
|
82
Biogen
BIIB
$19.4B
| $321M | 0.33% | 1,171,329 +169,942 | +17% | +$46.5M |
|
83
DXC Technology
DXC
$2.59B
| $313M | 0.32% | 3,117,747 +42,372 | +1% | +$4.26M |
|
84
Starbucks
SBUX
$100B
| $313M | 0.32% | 5,411,955 +214,216 | +4% | +$12.4M |
|
85
Zions Bancorporation
ZION
$8.56B
| $313M | 0.32% | 5,938,744 -362,643 | -6% | -$19.1M |
|
86
Emerson Electric
EMR
$74.3B
| $310M | 0.32% | 4,543,266 -982,042 | -18% | -$67.1M |
|
87
Ametek
AME
$42.7B
| $310M | 0.31% | 4,076,680 +8,882 | +0.2% | +$675K |
|
88
Bank of America Series L
BAC.PRL
$3.84B
| $309M | 0.31% | 239,614 +16,569 | +7% | +$21.4M |
|
89
Burlington
BURL
$18.3B
| $308M | 0.31% | 2,314,890 +1,017,288 | +78% | +$135M |
|
90
MetLife
MET
$54.1B
| $288M | 0.29% | 6,276,914 -349,083 | -5% | -$16M |
|
|
WRK
91
DELISTED
WestRock Company
WRK
| $284M | 0.29% | 4,430,156 -201,130 | -4% | -$12.9M |
|
92
Royal Caribbean
RCL
$98.7B
| $284M | 0.29% | 2,411,052 +35,177 | +1% | +$4.14M |
|
93
Broadcom
AVGO
$1.4T
| $281M | 0.29% | 1,190,766 -312,206 | -21% | -$73.6M |
|
94
Netflix
NFLX
$513B
| $275M | 0.28% | 932,272 +212,093 | +29% | +$62.6M |
|
95
M&T Bank
MTB
$31.5B
| $275M | 0.28% | 1,493,340 -90,746 | -6% | -$16.7M |
|
96
Gilead Sciences
GILD
$140B
| $275M | 0.28% | 3,647,110 +256,127 | +8% | +$19.3M |
|
97
Kellanova
K
$27.6B
| $274M | 0.28% | 4,221,683 +985,494 | +30% | +$64.1M |
|
98
Danaher
DHR
$147B
| $273M | 0.28% | 2,791,323 -41,143 | -1% | -$4.03M |
|
99
Amgen
AMGN
$155B
| $271M | 0.28% | 1,589,622 -117,892 | -7% | -$20.1M |
|
100
S&P Global
SPGI
$167B
| $270M | 0.27% | 1,414,243 +288,427 | +26% | +$55.1M |
|